Christopher Hite sold $5.9M of RPRX stock

Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc (RPRX), sold 100,000 shares of RPRX stock worth $5.9M, per an SEC Form 4 filed Sep 24, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 22, 2026, 2 days before it was made public.

RPRX has moved +17.9% since the trade date, from $58.52 to $68.97 (Nov 12, 2026 close).